- Home
- CRL vs PNR Comparison
CRL vs PNR Comparison
Compare CRL & PNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRL | PNR |
|---|---|---|
| Founded | 1947 | 1966 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 10.1B |
| IPO Year | 1999 | 2003 |
Fundamental Metrics
Financial Performance| Metric | CRL | PNR |
|---|---|---|
| Price | $224.30 | $63.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $198.27 | $109.73 |
| AVG Volume (30 Days) | 804.7K | ★ 3.1M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | N/A | ★ 5.88 |
| EPS | N/A | ★ 1.05 |
| Revenue | ★ $1,857,601,000.00 | N/A |
| Revenue This Year | N/A | $4.24 |
| Revenue Next Year | $3.04 | $4.82 |
| P/E Ratio | ★ N/A | $59.89 |
| Revenue Growth | ★ 10.48 | N/A |
| 52 Week Low | $144.26 | $57.60 |
| 52 Week High | $238.85 | $113.95 |
Technical Indicators
Market Signals| Indicator | CRL | PNR |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 34.76 |
| Support Level | $218.39 | $57.60 |
| Resistance Level | $232.94 | $77.03 |
| Average True Range (ATR) | 8.15 | 2.74 |
| MACD | -2.14 | -0.81 |
| Stochastic Oscillator | 45.70 | 29.42 |
Price Performance
Historical ComparisonAbout CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.